top of page

Jeremy Middleton

Jeremy Middleton

Jeremy D. Middleton joined AJK Biopharmaceutical, LLC as Chief Executive Officer in
October of 2022. He served as Vice President, Corporate Development at Elusys
Therapeutics from 2007 until it merged with Heat Biologics in 2022. Prior to Elusys, Jeremy was Vice President of Business Development at Valera Pharmaceuticals. He has
held positions of increasing responsibility at Neose Technologies, Abbott Laboratories,
BASF Pharma and Boots Pharmaceuticals. Jeremy holds a Bachelor of Science degree in
Applied Chemistry from De Montfort University in England.

bottom of page